Pilarify (piflufolastat F-18) injection QTY. 14
Ended Awarded
- Contract number
- N0025922F0091
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $49,190
Award facts
- Contract value 100% obligated
- $49,189.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10007, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc., is for the supply of PYLARIFY (piflufolastat F-18) injection to the Defense Health Agency (DHA). The $49,189.98 firm fixed-price contract was awarded on April 14, 2022 and has an ultimate completion date of April 18, 2022. The contract is a Blanket Purchase Agreement (BPA) call and is not designated as a set-aside. Lantheus Holdings, Inc., the parent company of Progenics Pharmaceuticals, is an active federal contractor providing radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents to government healthcare providers such as the Department of Veterans Affairs (VA) and the National Institutes of Health (NIH) Clinical Center. The company holds several significant Indefinite Delivery Vehicles (IDVs), including BPAs and Indefinite Delivery Contracts (IDCs), primarily under the Pharmaceuticals and Drugs Federal Supply Schedule.
Quick answers
Who was awarded contract N0025922F0091?
N0025922F0091 was awarded to Progenics Pharmaceuticals Inc. by Bureau of Medicine and Surgery (Department of the Navy) on April 14, 2022.
How much is contract N0025922F0091 worth?
The government has obligated $49,190 on N0025922F0091.
Which agency awarded contract N0025922F0091?
Bureau of Medicine and Surgery (Department of the Navy) awarded N0025922F0091, with funding from Defense Health Agency (Department of Defense).
Is contract N0025922F0091 an order under another contract?
Yes. N0025922F0091 is a BPA call under N0025922A0006, a blanket purchase agreement.
Was contract N0025922F0091 competed?
The extent of competition for N0025922F0091 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award